gentamicin A: see also records for gentamicin B and gentamicin C; structure given in first source [MeSH]
ID Source | ID |
---|---|
PubMed CID | 165365453 |
MeSH ID | M0097431 |
Synonym |
---|
gentamicin a |
13291-74-2 |
DTXSID501043050 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
gentamicin | 1964 | 2015 | 25.7 | high | 0 | 2 | 0 | 2 | 2 | 0 | |||
vancomycin | glycopeptide | antibacterial drug; antimicrobial agent; bacterial metabolite | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
clarithromycin | macrolide antibiotic | antibacterial drug; environmental contaminant; protein synthesis inhibitor; xenobiotic | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
2-deoxystreptamine | 2008 | 2008 | 16.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 | |||
paromamine | aminoglycoside; primary amino compound; triamine | 2008 | 2008 | 16.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 | ||
daptomycin | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cross Infection | 0 | 1964 | 1964 | 60.0 | high | 0 | 1 | 0 | 0 | 0 | 0 | |
Health Care Associated Infection | 0 | 1964 | 1964 | 60.0 | high | 0 | 1 | 0 | 0 | 0 | 0 | |
Infections, Staphylococcal | 0 | 1964 | 1964 | 60.0 | high | 0 | 1 | 0 | 0 | 0 | 0 | |
Staphylococcal Infections | 0 | 1964 | 1964 | 60.0 | high | 0 | 1 | 0 | 0 | 0 | 0 |
Article | Year |
---|---|
In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutions. BMC microbiology, , Oct-30, Volume: 15 | 2015 |